Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24618199 | 0.99 | MEN1 (0.31) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL23606107 | 0.98 | MEN1 (0.32) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL23606105 | 0.95 | MEN1 (0.32) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL24618047 | 0.94 | MEN1 (0.30) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL24618655 | 0.94 | MEN1 (0.32) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL24618105 | 0.92 | MEN1 (0.32) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24618103 | 0.92 | MEN1 (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL24618048 | 0.90 | PDK2 (0.32) | PDK2MEN1ALDH1A1MAPTHPGD | |
| SCHEMBL24618101 | 0.89 | MEN1 (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL24618043 | 0.89 | MEN1 (0.33) | PDK2MEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | EXOC1, EXOC4, CHRM1 | PDK2 2798/4885MEN1 2565/4885ALDH1A1 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.